Table 2. Clinical information and factors related in prognosis.
| Cases | Survival (month) | 95%CI | P-value | |
|---|---|---|---|---|
| Gender | 0.227 | |||
| Male | 34 | 55.404±4.195 | 47.181-63.627 | |
| Female | 27 | 59.960±3.330 | 53.432-66.488 | |
| Age | 0.037 | |||
| ≤60y | 36 | 47.857±3.600 | 40.802-54.913 | |
| >60y | 25 | 65.771±2.893 | 60.101-71.441 | |
| Pathological grades | 0.770 | |||
| G1 | 13 | 40.092±2.703 | 34.794-45.391 | |
| G2 | 45 | 57.954±3.393 | 51.305-64.604 | |
| G3 | 3 | 49.333±13.608 | 22.661-76.006 | |
| Nerve and vascular invasion | 0.032 | |||
| No | 52 | 60.949±2.765 | 55.529-66.369 | |
| Yes | 9 | 42.333±9.223 | 24.256-60.410 | |
| Tumor status | 0.000 | |||
| No recurrence | 48 | 64.268±2.442 | 59.483-69.054 | |
| Recurrence | 13 | 30.923±4.992 | 21.139-40.707 | |
| N stage | 0.013 | |||
| N0 | 27 | 63.537±2.397 | 58.839-68.236 | |
| N1-2 | 34 | 51.835±4.514 | 42.988-60.683 | |
| Neck status | 0.000 | |||
| CLNM- | 27 | 63.537±2.397 | 58.839-68.236 | |
| CLNM+(none of recurrence) | 20 | 60.850±4.873 | 52.300-70.400 | |
| CLNM+(recurrence after ND) | 14 | 31.923±4.695 | 22.721-41.125 | |
| MFAP5 Scores | 0.047 | |||
| - | 24 | 65.785±2.902 | 60.096-71.474 | |
| + | 37 | 50.929±3.840 | 43.404-58.455 | |
| TNNC1 Scores | 0.047 | |||
| - | 19 | 64.000±2.920 | 58.277-69.723 | |
| + | 42 | 54.619±3.782 | 47.206-62.032 | |
| MFAP5 and TNNC1 Scores | 0.030 | |||
| 0 | 14 | 62.929±3.923 | 55.239-70.618 | |
| +- | 15 | 67.571±2.340 | 62.985-72.158 | |
| ++ | 32 | 48.516±4.302 | 40.084-56.947 |